Items to be procured by the SE "MPU" in 2021
International Nonproprietary Names (INN) |
Form |
Dosage |
Chemotherapy medicines, radiopharmaceuticals and medicines that support treatment of cancer patients |
||
Abiraterone |
tablets, capsules, pills |
250 mg |
Anagrelide |
-“- |
0,5 mg |
Azacitidine |
tablets, capsules, pills |
100 mg |
Bikalutamid |
tablets, capsules, pills |
50 mg |
Bikalutamid |
-“- |
150 mg |
Bleomycin |
ampoules, vials, syringes |
15 mg (15 МО) |
Vincristine |
-“- |
1 мг |
Vinorelbine |
-“- |
50 mg |
Gemcitabine |
-“- |
200 mg |
Gemcitabine |
-“- |
1 000 mg |
Goserelin |
-“- |
10,8 mg |
Goserelin |
-“- |
3,6 mg |
Dakarbazin |
ampoules, vials, syringes |
200 mg |
Doxorubicin |
-“- |
50 mg |
Docetaxel |
-“- |
80 mg |
Docetaxel |
-“- |
20 mg |
Exemestane |
tablets, capsules, pills |
25 mg |
Everolimus |
-“- |
2,5 мг |
Everolimus |
-“- |
5 mg |
Everolimus |
-“- |
10 mg |
Etoposide |
ampoules, vials, syringes |
100 mg |
Irinotecan |
-“- |
100 mg |
Capecitabine |
tablets, capsules, pills |
150 mg |
Capecitabine |
-“- |
500 mg |
Zoledronic acid |
ampoules, vials, syringes |
4 mg |
Letrozole |
tablets, capsules, pills |
2,5 mg |
Methotrexate |
ampoules, vials, syringes |
50 мг |
Paclitaxel |
-“- |
100 mg |
Topotecan |
-“- |
4 mg |
Trastuzumab |
-“- |
150 mg |
Filgrastim |
-“- |
48 mln МО |
Fluorouracil |
-“- |
500 mg |
Cisplatin |
-“- |
50 mg |
Cisplatin |
-“- |
100 mg |
Methotrexate |
-“- |
1 000 mg |
Paclitaxel |
ampoules, vials, syringes |
30 mg |
Doxorubicin |
-“- |
100 mg |
Irinotecan |
-“- |
300 mg |
Cabazitaxel |
-“- |
60 mg |
Calcium folinate |
-“- |
100 mg |
Calcium folinate |
-“- |
50 mg |
Carboplatin |
-“- |
150 mg |
Carboplatin |
-“- |
450 mg |
Epirubicin |
-“- |
50 mg |
Epirubicin |
-“- |
10 mg |
Ifosfamide |
-“- |
1 000 mg |
Interferon alfa-2b |
-“- |
3 mln МО |
Sodium iodide (131I) |
solution for injection |
4 000 МБк |
Sodium iodide (131I) |
pills |
4 000 МБк |
Samarium (153Sm) lexidrons |
solution for injection |
2 000 МБк у флаконах об’ємом по 10 мл |
Technetium (99mTc) |
radionuclide generator (by elution from a 99mTc generator a solution in a vial is obtained) |
15 000 МБк |
Tamoxifen |
tablets, capsules, pills |
20 mg |
Temozolomide |
-“- |
20 mg |
Temozolomide |
-“- |
100 mg |
Temozolomide |
-“- |
250 mg |
Erlotinib |
-“- |
150 mg |
Mesna |
ampoules, vials, syringes |
400 mg |
Oxaliplatin |
-“- |
50 mg |
Oxaliplatin |
-“- |
100 mg |
Asparaginase |
-“- |
10 000 МО |
Pegaspargaz |
-“- |
3 750 МО |
Posaconazole |
-“- |
105 mg (40 mg/ml) |
Bendamustine |
-“- |
25 mg |
Bendamustine |
-“- |
100 mg |
Bortezomib |
-“- |
1 mg |
Bortezomib |
-“- |
3,5 mg |
Vancomycin |
-“- |
500 mg |
Vinblastine |
-“- |
10 mg |
Voriconazole |
tablets, capsules, pills |
200 mg |
Hydroxyurea |
-“- |
500 mg |
Etoposide |
ampoules, vials, syringes |
200 mg |
Idarubicin |
-“- |
5 mg |
Calcium folinate |
-“- |
30 mg |
Lomustine |
tablets, capsules, pills |
40 mg |
Mitoxantrone |
ampoules, vials, syringes |
20 mg |
Melphalan |
tablets, capsules, pills |
2 mg |
Piperaschilin / tazobactam |
ampoules, vials, syringes |
4 500 mg (4 000 mg/ 500 mg) |
Procarbazine |
tablets, capsules, pills |
50 mg |
Pomalidomide |
-“- |
4 mg |
Pemetrexed |
ampoules, vials, syringes |
100 mg |
Pemetrexed |
-“- |
500 mg |
Rituximab |
-“- |
100 mg |
Rituximab |
-“- |
500 mg |
Sunitinib or pazopanib |
tablets, capsules, pills |
12,5 mg або 400 мг |
Sunitinib |
-“- |
12,5 mg |
Sunitinib |
-“- |
25 mg |
Sunitinib |
-“- |
50 mg |
Thalidomide |
-“- |
100 mg |
Fludarabine |
ampoules, vials, syringes |
50 mg |
Fulvestrant |
-“- |
250 mg |
Cyclophosphamide |
-“- |
500 mg |
Cytarabine |
-“- |
1 000 mg |
Cytarabine |
-“- |
100 mg |
Voriconazole |
-“- |
200 mg |
Cladribine |
ampoules, vials, syringes |
10 mg |
Chlorambucil |
tablets, capsules, pills |
2 mg |
Daunorubicin |
ampoules, vials, syringes |
20 mg |
Lenalidomide |
tablets, capsules, pills |
10 mg |
Lenalidomide |
-“- |
25 mg |
6-Mercaptopurine |
-“- |
50 mg |
Amphotericin B-lipid complex |
ampoules, vials, syringes |
50 mg |
Imatinib |
tablets, capsules, pills |
100 mg |
Imatinib |
-“- |
400 mg |
Nilotinib |
-“- |
200 mg |
Bozutinib |
-“- |
100 mg |
Bozutinib |
-“- |
500 mg |
Dasatinib |
-“- |
50 mg |
Dasatinib |
-“- |
70 mg |
Medicines and medical devices for the treatment of children with cancer and oncohematological diseases
Amphotericin
B-lipid complex |
ampoules, vials
|
50 mg
|
Amphotericin
B is liposomal |
-“-
|
50 mg
|
Horse antithymocyte
globulin |
ampoules, vials
|
250 mg
|
Rabbit antithymocyte
globulin |
-“-
|
25 mg
|
Asparaginase
|
ampoules, vials, syringes
|
10 000 МО
|
Acyclovir
|
-“-
|
250 mg
|
Bleomycin
|
ampoules, vials
|
15 mg (15 МО)
|
Busulfan
|
tablets, capsules, pills
|
2 mg
|
Busulfan
|
ampoules, vials
|
60 mg
|
Vancomycin
|
-“-
|
500 mg
|
Vinblastine
|
ampoules, vials
|
5 mg/5 ml or 10 mg/ 10 ml
|
Vincristine
|
ampoules, vials, syringes
|
1 mg
|
Vinorelbine
|
-“-
|
10 mg
|
Voriconazole
|
-“-
|
200 mg
|
Voriconazole
|
tablets, capsules, pills
|
200 mg
|
Ganciclovir
|
ampoules, vials, syringes
|
500 mg
|
Gemcitabine
|
-“-
|
1 000 mg
|
Hydrocortisone
|
-“-
|
100 mg
|
Dakarbazin
|
ampoules, vials
|
100 mg
|
Dakarbazin
|
-“-
|
200 mg
|
Dactinomycin
|
ampoules, vials, syringes
|
0,5 mg
|
Daptomycin
|
-“-
|
350 mg
|
Deferasirox
|
tablets, capsules, pills
|
180 mg or 250 mg
|
Doxorubicin
|
ampoules, vials, syringes
|
50 mg
|
Doxorubicin
|
-“-
|
10 mg
|
Doripenem
|
-“-
|
500 mg
|
Enoxaparin sodium
|
ampoules, vials, syringes
|
10 000 анти-Ха МО/ml
|
Erythropoietin
(epoetin-alpha) |
-“-
|
10 000 МО
|
Erythropoietin
(epoetin-alpha) |
-“-
|
20 000 МО
|
Erythropoietin
(epoetin-alpha) |
-“-
|
40 000 МО
|
Etoposide
|
-“-
|
200 mg
|
Idarubicin
|
-“-
|
5 mg
|
Fentanyl
|
transdermal patch
|
25 мкг/год
|
Fentanyl
|
-“-
|
50 мкг/год
|
Fentanyl
|
-“-
|
75 мкг/год
|
Fentanyl
|
-“-
|
100 мкг/год
|
Isotretinoin
|
tablets, capsules, pills
|
20 mg
|
Isotretinoin
|
-“-
|
10 mg
|
Imatinib
|
-“-
|
400 mg
|
Imatinib
|
-“-
|
100 mg
|
Imipenem in combination
with cilastatin |
ampoules, vials, syringes
|
500 mg/500 mg
|
Human immunoglobulin
is normal for intravenous administration |
-“-
|
2,5 g (5 %)
or 5 g (10 %) per 50 ml |
Solution for parenteral
nutrition (combinations, amino acids without fat / lipid emulsions) |
vials, bottles, bags, containers
|
|
Solution for parenteral
nutrition (combinations, amino acids with fat / lipid emulsions) |
-“-
|
|
Irinotecan
|
ampoules, vials, syringes
|
40 mg
|
Itraconazole
|
-“-
|
150 ml (10 mg/ml)
|
Ifosfamide
|
-“-
|
1 000 mg
|
Calcium folinate
|
-“-
|
30 mg
|
Carboplatin
|
-“-
|
50 mg
|
Caspofungin
|
-“-
|
50 mg
|
Sodium colistimethate
|
-“-
|
2 000 000 МО
|
Lenograstim
|
-“-
|
33,6 mln МО
|
Linezolid
|
solution for infusion in systems
|
300 ml (2 mg/ml)
|
Linezolid
|
solution for infusion
|
300 ml (2 mg/ml)
|
Linezolid
|
-“-
|
100 ml (2 mg/ml)
|
Lomustine
|
tablets, capsules, pills
|
40 mg
|
Melphalan
|
ampoules, vials, syringes
|
50 mg
|
Mercaptopurine
|
tablets, capsules, pills
|
50 mg
|
Meropenem
|
ampoules, vials, syringes
|
500 mg
|
Meat
|
-“-
|
400 mg
|
Methylprednisolone
|
-“-
|
500 mg
|
Methotrexate
|
tablets, capsules, pills
|
2,5 mg
|
Methotrexate
|
ampoules, vials, syringes
|
1 000 mg
|
Methotrexate
|
-“-
|
5 000 mg
|
Methotrexate
|
-“-
|
25 mg/ml
per 2 ml |
Methotrexate
|
-“-
|
10 mg/ml
per 5 ml |
Micafungin
|
-“-
|
100 mg
|
Micafungin
|
-“-
|
50 mg
|
Mitoxantrone
|
ampoules, vials
|
10 mg
|
Mitoxantrone
|
-“-
|
20 mg
|
Morphine sulfate
|
oral solution, vials
|
2 mg/ml
|
Nilotinib
|
tablets, capsules, pills
|
200 mg
|
Ondansetron
|
ampoules, vials, syringes
|
4 mg
|
Pegaspargaz
|
-“-
|
3 750 МО
|
Pegfilgrastim
|
-“-
|
6 mg/0,6 ml
|
Piperacillin / Tazobactam
|
-“-
|
4 g/0,5 g
|
Posaconazole
|
-“-
|
105 ml
(40 mg/ml) |
Procarbazine
|
tablets, capsules
|
50 mg
|
Rituximab
|
ampoules, vials, syringes
|
100 mg
|
Rituximab
|
-“-
|
500 mg
|
Sulbactam / cefaperazone
|
-“-
|
0,5 g/0,5 g
|
Taigecycline
|
vials
|
50 mg
|
Tacrolimus
|
tablets, capsules, pills
|
0,5 mg
|
Tacrolimus
|
-“-
|
1 mg
|
Tacrolimus
|
-“-
|
5 mg
|
Tacrolimus
|
ampoules, vials, syringes
|
5 mg/ml
|
Teicoplanin
|
-“-
|
400 mg
|
Temozolomide
|
-“-
|
100 mg
|
Temozolomide
|
tablets, capsules, pills
|
20 mg
|
Temozolomide
|
-“-
|
100 mg
|
Thioguanine
|
-“-
|
40 mg
|
Topotecan
|
ampoules, vials, syringes
|
4 mg
|
Treosulfan
|
-“-
|
1 g
|
Treosulfan
|
-“-
|
5 g
|
Tretinoin
|
tablets, capsules, pills
|
10 mg
|
Thiotepa
|
ampoules, vials
|
100 mg
|
Filgrastim
|
ampoules, vials, syringes
|
30 mln МО
|
Fludarabine
|
-“-
|
50 mg
|
Fluconazole
|
ampoules, vials
|
2 mg/ml
(per 100 ml) |
Fosfomycin
|
ampoules, vials, syringes
|
2 g
|
Cefepime
|
-“-
|
1 000 mg
|
Cyclosporine
|
vials, oral solution
|
5 000 mg
|
Cyclosporine
|
ampoules, vials, syringes
|
50 mg
|
Cyclosporine
|
tablets, capsules, pills
|
25 mg
|
Cyclosporine
|
-“-
|
50 mg
|
Cyclosporine
|
-“-
|
100 mg
|
Cyclophosphamide
|
-“-
|
50 mg
|
Cyclophosphamide
|
ampoules, vials, syringes
|
1 000 mg
|
Cyclophosphamide
|
ampoules, vials
|
200 mg
|
Cisplatin
|
ampoules, vials, syringes
|
50 mg
|
Cytarabine
|
-“-
|
100 mg
|
Cytarabine
|
-“-
|
1 000 mg
|
Filters or device for removal of leukocytes from thromboconcentrate (for bed use) |
pcs |
|
Infusion filters (96-hour) |
-“- |
|
Filters or device for removing leukocytes from erythrocyte mass (for bed use) |
-“- |
|
SAG-M stabilizer, packages with solution, 100 ml |
-“- |
|
Double PLASMAFLEX / BLUEFLEX container for Macotronic or equivalent |
-“- |
|
Container for cryo-freezing |
-“- |
|
Container with a solution of anticoagulant ACD-A for apheresis |
-“- |
|
Container for collecting bone marrow |
-“- |
|
C5L set for thrombocytopheresis (shelf life 5 days) |
sets |
|
C4L set for thrombocytopheresis (shelf life 5 days) |
-“- |
|
Optia collection kit for SpectraOptia apheresis system or equivalent |
-“- |
|
Amicus apheresis kit MNC with double-needle access or equivalent |
-“- |
|
Kit for automatic cytopheresis of blood cells to the Amicus cell separator single-needle or equivalent |
-“- |
|
Kit for automatic cytopheresis of blood cells to Amicus cell separator double-needle or equivalent |
-“- |
|
TrimaAccel kit for LRS platelets, plasma and erythrocytes to the TrimaAccel automatic blood component collection system or equivalent |
-“- |
|
S5L kit for platelet apheresis, single-needle connection, or equivalent |
sets |
|
PIR kit to COM.TEC blood cell separator or equivalent |
-“- |
|
Kit C4Y for collecting lymphocytes or peripheral blood stem cells to the COM.TEC blood cell separator or equivalent |
-“- |
|
Central venous catheterization kit two-way pediatric 5 Fr BBraun or equivalent |
pcs |
|
Central venous catheterization kit two-way 7 Fr BBraun or equivalent |
-“- |
|
Central venous catheterization kit two-way 7 Fr type Hickman® or equivalent |
-“- |
|
Set for catheterization of central veins one- or two-way 4-5 Fr type Broviac or equivalent |
pcs |
|
Central venous catheterization kit two-way 6-7 Fr type Broviac or equivalent |
-“- |
|
Port-operated central venous catheter type Port-a-Cath or equivalent 5 Fr |
-“- |
|
Port-operated central venous catheter type Port-a-Cath or equivalent 6.5 Fr |
-“- |
|
Port-operated central venous catheter type Port-a-Cath or equivalent 7 Fr |
-“- |
|
Huber's needle (Huber) |
-“- |
|
Medicines for children with type A or B haemophilia or Willebrand's disease
Human blood coagulation factor VIII |
vitals |
250 МО |
Human blood coagulation factor VIII |
vials |
500 МО |
Human blood coagulation factor VIII |
-“- |
1 000 МО |
Human blood coagulation factor VIII |
-“- |
1 500 МО |
Human blood coagulation factor VIII |
-“- |
250 МО |
Human blood coagulation factor VIII |
-“- |
500 МО |
Human blood coagulation factor VIII |
-“- |
1 000 МО |
Human blood coagulation factor IX |
-“- |
500 МО |
Human blood coagulation factor IX |
-“- |
500 МО and/or 600 МО |
Human blood coagulation factor IX |
-“- |
1 000 МО |
Human blood coagulation factor IX |
-“- |
1 000 МО and/or 1 200 МО |
Human blood coagulation factor VIII |
-“- |
500 МО |
Human blood coagulation factor VIII |
vials |
1 000 МО |
Human blood coagulation factor |
-“- |
1 000 МО |
Eptacog-alpha |
-“- |
2 mg (100 КМО) |
Eptacog-alpha |
-“- |
5 mg (250 КМО) |
Antiinhibitory coagulant complex |
-“- |
500 МО |
Antiinhibitory coagulant complex |
-“- |
1 000 МО |
Emicizumab |
-“- |
30 mg |
Emicizumab |
-“- |
60 mg |
Emicizumab |
-“- |
105 mg |
Desmopressin |
ampoules, vials,syringes |
15 мкг/ml, 1 mg |
Human blood coagulation factor VIII and human |
vials |
500 МО |
Human blood coagulation factor VIII and human |
vials |
1 000 МО |
Human blood coagulationfactor VIII (plasma) |
ampoules, vials, syringes |
|
Human blood coagulation factor VIII (plasma) |
-“- |
1 000 МО |
Human blood coagulation factor VIII (recombinant) |
-“- |
500 МО |
Human blood coagulation factor VIII (recombinant) |
-“- |
1 000 МО |
Human blood coagulation factor VIII (recombinant) |
-“- |
1 500 МО |
Human blood coagulation factor VIII (recombinant) |
-“- |
2 000 МО |
Human blood coagulation factor VIII (recombinant) |
-“- |
3 000 МО |
Human blood coagulation factor IX (plasma) |
-“- |
500 МО and/or 600 МО |
Human blood coagulation factor IX (plasma) |
ampoules, vials, syringes |
1 000 МО and/or 1 200 МО |
Human blood coagulation factor IX (recombinant) |
-“- |
500 МО |
Human blood coagulation factor IX (recombinant) |
-“- |
1 000 МО |
Human blood coagulation factor VIII and Willebrand factor |
-“- |
500 МО |
Human blood coagulation factor VIII and Willebrand factor |
-“- |
1 000 МО |
Human blood coagulation factor VIII and Willebrand factor |
-“- |
500 МО |
Human blood coagulation factor VIII and Willebrand factor |
-“- |
1 000 МО |
Eptacog-alpha activated (recombinant factor VIIa) |
-“- |
2 mg (100 КМО) |
Eptacog-alpha activated (recombinant factor VIIa) |
ampoules, vials, syringes |
5 mg (250 КМО) |
Antiinhibitory coagulant complex |
-“- |
500 МО |
Antiinhibitory coagulant complex |
-“- |
1 000 МО |
Desmopressin |
-“- |
15 мкг/мл, 1 мл |
Medicines and medical devices for healthcare facilities to provide treatment for patients with cardiovascular and cerebrovascular diseases
Coronary stent system with medical coating |
pcs |
|
Coronary stent system with medical coating for the treatment |
-“- |
|
Coronary stent system with medical coating |
-“- |
|
Coronary balloon catheter |
-“- |
|
Coronary balloon catheter for predilatation |
pcs |
|
Coronary balloon catheter for |
-“- |
|
Coronary balloon catheter |
-“- |
|
Coronary conductor for complex |
-“- |
|
Coronary conductor |
-“- |
|
Coronary conductor for standard situations |
-“- |
|
Guiding catheter |
-“- |
|
Medical products for coronary angiography: set for coronary angiography (catheter JL4 -1 piece, catheter JR4 - 1 piece, catheter PIG - 1 piece, conductor - 1 piece, introducer - 1 piece) |
sets |
|
Medical devices for coronary angiography: set for coronary angiography for transradial access (angiographic catheter - 2 pieces, angiographic conductor - 1 piece, introducer - 1 piece) |
-“- |
|
Aspiration catheter |
pcs |
|
Introducer |
-“- |
|
Inflation device |
-“- |
|
Enoxaparin sodium |
ampoules, vials, syringes |
10 000 анти-ХаМО/мл |
|
Fondaparinux sodium |
-“- |
0,5 мл |
|
Metoprolol |
-“- |
5 мл (1 мг/мл) |
|
Dobutamine |
ampoules, vials |
250 мг |
|
Norepinephrine |
ampoules |
норадреналіну |
|
Milrinon |
ampoules, vials |
1 мг/мл |
|
X-ray contrast iodine-containing |
ampoules, vials, syringes |
100 мл |
|
X-ray contrast iodine-containing |
-“- |
50 мл |
|
X-ray contrast iodine-containing |
-“- |
50 мл |
|
X-ray contrast iodine-containing |
-“- |
50 мл |
|
Plate hemostatic |
covered plate |
|
|
Single-chamber frequency-adapted artificial driver |
pcs |
|
Two-chamber artificial driver of a heart rate (SHVRS) |
-“- |
|
Two-chamber frequency-adapted artificial driver |
-“- |
|
Two-chamber frequency-adapted artificial pacemaker |
pcs |
|
Resynchronized artificial heart rate driver (SHVRS) |
-“- |
|
Cardioverter-defibrillator with the possibility |
-“- |
|
Cardioverter-defibrillator single-chamber |
-“- |
|
The cardioverter-defibrillator is two-chamber |
-“- |
|
The guided ablation catheter is unidirectional |
-“- |
|
The guided ablation catheter is bidirectional |
-“- |
|
The guided ablation catheter is irrigated unidirectional |
-“- |
|
The guided ablation catheter is irrigated bidirectionally |
-“- |
|
The guided ablation catheter is unidirectional |
-“- |
|
20-pole guided electrophysiological diagnostic |
-“- |
|
Guided electrophysiological diagnostic catheter 4-pole |
-“- |
|
Guided electrophysiological diagnostic |
-“- |
|
Reference electrode for navigation systems |
-“- |
|
Electrode for epicardial constant stimulation with steroid impregnation |
-“- |
|
Electrode wire for temporary endocardial pacing |
-“- |
|
Introducer for atrial puncture |
-“- |
|
System for cooling ablative irrigated catheters |
-“- |
|
Oxygenator for newborns and infants up to 5 kg |
sets |
|
Oxygenator for infants and young children |
sets |
|
Oxygenator for children and adolescents |
-“- |
|
Oxygenator for adults more than 50 kg with a set of main pipes |
-“- |
|
Kit for the procedure of continuous life support |
-“- |
|
Kit for the procedure of continuous life support |
-“- |
|
Hemoconcentrator for babies |
pcs |
|
Hemoconcentrator for children up to 15 kg |
-“- |
|
Atraumatic suture material: thread (coated polyester, braided thread), |
-“- |
|
Atraumatic suture material: thread (coated polyester, braided thread), |
-“- |
|
Atraumatic suture material: steel surgical wire (monofilament thread), |
-“- |
|
Atraumatic suture material: steel surgical wire (monofilament thread), |
-“- |
|
Thread polytetrafluoroethylene (PTFE), |
pcs |
|
Cartridge with clips, 6 titanium clips in the cartridge (medium). Sterile |
cartridges |
|
The heart valve is biological mitral |
pcs |
|
The heart valve is biological aortic |
-“- |
|
The heart valve is mechanical two-leaf for prosthetics of the aortic valve |
-“- |
|
The heart valve mechanical two-leaf for prosthetics of the mitral valve |
-“- |
|
Ring for anuloloplasty of the mitral valve |
-“- |
|
Ring for annuloplasty of the tricuspid valve |
-“- |
|
Valve-containing conduit |
-“- |
|
Set of cannulas for operations with artificial circulation |
-“- |
|
Set for the device of measurement of the activated time of coagulation |
-“- |
|
Electrode wire for temporary pacing 0.9 m long |
-“- |
|
Biological prosthesis for pericardial and |
-“- |
|
Medical device for endovascular surgery |
-“- |
|
Medical device for endovascular surgery |
-“- |
|
Medical device for endovascular surgery |
-“- |
|
Medical device for endovascular operation |
pcs |
|
Medical device for stenting of carotid arteries, |
-“- |
|
Medical product for carotid artery stenting, |
-“- |
|
Medical product for carotid artery stenting, |
-“- |
|
Medical devices for stenting of carotid arteries, |
-“- |
|
Medical product for stenting of carotid arteries, |
-“- |
|
Balloon catheter for exclusion |
-“- |
|
Cylinder-catheter for exclusion |
-“- |
|
Cylinder-catheter for exclusion |
-“- |
|
Intracranial stent for cerebral aneurysms with a wide neck |
-“- |
|
Catheter balloon for cerebral aneurysms with a wide neck |
-“- |
|
Medical device for diagnostic cerebral angiography, |
-“- |
|
Medical device for diagnostic cerebral angiography, |
-“- |
|
Medical device for diagnostic cerebral angiography, |
-“- |
|
Medical device for diagnostic cerebral angiography, |
pcs |
|
Clips for direct exclusion of cerebral aneurysms |
-“- |
|
Medical device for embolization of arteriovenous |
-“- |
|
Medical device for embolization of arteriovenous malformations of the brain, which includes a microcatheter - 1 piece |
-“- |
|
Medical device for embolization of arteriovenous malformations of the brain, which includes a microconductor - 1 piece |
-“- |
|
Medical device for embolization of arteriovenous malformations of the brain, which includes an introducer - 1 piece |
-“- |
|
Medical device for embolization of arteriovenous malformations of the brain, which includes a conductive catheter - 1 piece |
-“- |
|
Local hemostatic surgical material for neurosurgical operations: hemostatic tissue made of oxidized regenerated resorbable cellulose - 1 piece |
-“- |
|
Local hemostatic surgical material for neurosurgical operations: hemostatic cotton wool from oxidized regenerated resorbable cellulose - 1 piece |
-“- |
|
Extended conductive catheter for distal endovascular access - 1 piece |
-“- |
|
Flow-directing stent for large and giant cerebral aneurysms - 1 piece |
-“- |
|
Device for extraction of thrombi from cerebral arteries |
-“- |
|
Woven vascular prosthesis (TSP) made of polyester, coated with bovine collagen or gelatin coating, length not less than 12.5-25 cm, diameter 14 mm |
-“- |
|
Woven vascular prosthesis (TSP) made of polyester, coated with bovine collagen or gelatin coating, length not less than 12.5-25 cm, diameter 16 mm |
pcs |
|
Woven vascular prosthesis (TSP) made of polyester, coated with bovine collagen or gelatin coating, length not less than 12.5-25 cm, diameter 18 mm |
-“- |
|
Woven vascular prosthesis (TSP) made of polyester, coated with bovine collagen or gelatin coating, length not less than 12.5-25 cm, diameter 20 mm |
-“- |
|
Thin-walled vascular prosthesis (TSP) with e-PTFE, length 10 cm, diameter 5 mm |
-“- |
|
Knitted vascular prosthesis (VSP) made of polyester, coated with bovine collagen or gelatin coating, length 40 cm, diameter 8 mm |
-“- |
|
Knitted vascular prosthesis (VSP) made of polyester, coated with bovine collagen or gelatin coating, length 40 cm, diameter 10 mm |
-“- |
|
Bifurcated vascular prosthesis knitted (BSPV) made of polyester, coated with bovine collagen or gelatin coating, not less than 40 cm, diameter 16 x 8 mm |
-“- |
|
Bifurcated vascular prosthesis knitted (BSPV) made of polyester, coated with bovine collagen or gelatin coating, not less than 40 cm, diameter 18 x 9 mm |
-“- |
|
Bifurcated vascular prosthesis knitted (BSPV) made of polyester, coated with bovine collagen or gelatin coating, not less than 40 cm, diameter 20 x 10 mm |
-“- |
|
Thin-walled vascular cone-shaped prosthesis (TSKP) with e-PTFE, length 70 cm, diameter 7-4 mm |
sets |
|
Thin-walled vascular cone-shaped prosthesis (TSKP) with e-PTFE, length 70 cm, diameter 8-5 mm |
-“- |
|
Thin-walled vascular prosthesis (TSP) with e-PTFE with removable spiral reinforcement, length 70 cm, diameter 8 mm |
-“- |
|
Thin-walled vascular prosthesis (TSP) with e-PTFE with cuff, length 50 cm, diameter 7 mm |
sets |
|
Thin-walled vascular prosthesis (TSP) with e-PTFE with cuff, length 50 cm, diameter 8 mm |
-“- |
|
Thin-walled vascular prosthesis (TSP) with e-PTFE with cuff, length 60 cm, diameter 7 mm |
-“- |
|
Thin-walled vascular prosthesis (TSP) with e-PTFE with cuff, length 60 cm, diameter 8 mm |
-“- |
|
Thin-walled vascular cone-shaped prosthesis (TSKP) with e-PTFE with spiral reinforcement, length 70 cm, diameter 8-5 mm |
-“- |
|
Double-layer vascular prosthesis made of dacron or polytetrafluoroethylene (PTFE), length 70 cm, diameter 6 mm |
pcs |
|
Woven vascular prosthesis (TSP) made of polyester, coated with bovine collagen or gelatin, for the treatment of aortic aneurysms, diameter 22 mm |
-“- |
|
Woven vascular prosthesis (TSP) made of polyester, coated with bovine collagen or gelatin, for the treatment of aortic aneurysms, diameter 24 mm |
-“- |
|
Woven vascular prosthesis (TSP) made of polyester, coated with bovine collagen or gelatin, for the treatment of aortic aneurysms, diameter 26 mm |
-“- |
|
Fabric vascular prosthesis (TSP) made of polyester, coated with bovine collagen or gelatin, for the treatment of aortic aneurysms, diameter 28 mm |
-“- |
|
Fabric vascular prosthesis (TSP) made of polyester, coated with bovine collagen or gelatin, for the treatment of aortic aneurysms, diameter 30 mm |
-“- |
|
Fabric vascular prosthesis (TSP) made of polyester, coated with bovine collagen or gelatin, for the treatment of aortic aneurysms, diameter 32 mm |
-“- |
|
Woven vascular prosthesis (TSP) made of polyester, coated with collagen or gelatin, four-arm, for the treatment of aortic arch aneurysms, diameter 26 mm |
-“- |
|
Woven vascular prosthesis (TSP) made of polyester, coated with collagen or gelatin, four-branded, for the treatment of aortic arch aneurysms, diameter 28 mm |
-“- |
|
Woven vascular prosthesis (TSP) made of polyester, coated with collagen or gelatin, four-branded, for the treatment of aortic arch aneurysms, diameter 30 mm |
pcs |
|
Swan-Hans catheter without thermodilution sensor |
-“- |
|
Swan-Hans catheter with thermodilution sensor |
-“- |
|
Intraaortic balloon catheter (balloon for counterpulsator) |
-“- |
|
Device for myocardial biopsy |
-“- |
|
Nickel-titanium alloy occluder with dacron filling complete with delivery system to close the atrial septal defect |
sets |
|
Nickel-titanium alloy occluder with dacron filling complete with delivery system to close the interventricular septal muscle defect |
-“- |
|
Nickel-titanium alloy occluder with dacron filling complete with delivery system for arterial duct closure |
-“- |
|
Spiral system to eliminate the defect of the open ductus arteriosus |
pcs |
|
Atrioseptostomy balloon catheter |
-“- |
|
Pediatric balloon catheter for pulmonary valvuloplasty |
-“- |
|
The stent system is peripheral for large vessels |
-“- |
|
Medical devices for citizens suffering from idiopathic dystonia, torticollis, idiopathic oromandibular dystonia
Neurostimulation system for primary surgery for deep brain stimulation: set of electrodes for deep brain stimulation - 2 pieces, extender to electrodes - 2 pieces, milling hole cover - 2 pieces, multiprogrammed neurostimulator - 1 piece, patient programmer - 1 piece |
sets |
|
Neurostimulation system for reimplantation surgery for deep brain stimulation: programmable rechargeable neurostimulator, compatible with already implanted quadripolar extension lines and electrodes - 1 piece, charger for neurostimulator - 1 piece, patient programmer - 1 piece |
sets |
|
Medicines for the treatment of patients with multiple sclerosis
Interferon beta-1b |
ampoules, vials, |
9 600 000 МО |
|
Interferon beta-1a |
-“- |
6 000 000 МО |
|
Glatiramer acetate |
-“- |
40 mg |
|
Glatiramer acetate |
-“- |
20 mg |
|
Methylprednisolone |
-“- |
1 000 mg |
|
Mitoxantrone |
-“- |
2 mg/ml per 5 ml |
|
Fingolimod |
pills |
0,5 ml |
|
Medicines for the treatment of citizens suffering from a resistant form of juvenile rheumatoid arthritis
Adalimumab |
ampoules, vials, syringes |
40 mg |
Tocilizumab |
-“- |
80 mg/4 ml |
Tocilizumab |
-“- |
200 mg/10 ml |
Tocilizumab |
pre-filled syringe |
162 mg/0,9 ml |
Etanercept |
-“- |
0,5 ml (25 mg) |
Etanercept |
-“- |
1 ml (50 mg) |
Golimumab |
-“- |
50 mg/0,5 ml |
Adalimumab |
ampoules, vials, syringes |
20 mg |
Reagents for the mass screening of newborns for phenylketonuria, congenital hypothyroidism, cystic fibrosis and congenital adrenal hyperplasia
Test kit for screening newborns for phenylketonuria in blood samples dried on filter paper |
|
|
||
Test kit for screening newborns for congenital hypothyroidism in blood samples dried on filter paper |
-“- |
|
||
Test kit for screening newborns for cystic fibrosis in blood samples dried on filter paper |
-“- |
|
||
Test kit for screening newborns for adrenogenital syndrome in blood samples dried on filter paper |
-“- |
|
||
Kit for determining the most common mutations in the CFTR gene by LIPA |
-“- |
|
||
Paper test form for blood sampling of newborns |
pcs |
|
||
Immunological tablet with a U-shaped bottom |
-“- |
|
Medicines for citizens with congenital immunodeficiency disorders
Human immunoglobulin is normal for subcutaneous administration |
vials |
50 ml, 5 % (50 mg/ml) |
Human immunoglobulin is normal for subcutaneous administration |
-“- |
100 ml, 5 % (50 mg/ml) |
Human immunoglobulin is normal for subcutaneous administration |
-“- |
50 ml, 10 % (100 mg/ml) |
Human immunoglobulin is normal for subcutaneous administration |
-“- |
100 ml, 10 % (100 mg/ml) |
Human immunoglobulin is normal for subcutaneous administration |
-“- |
10 ml, 15-20 % (150-200 mg/ml) |
Human immunoglobulin is normal for subcutaneous administration |
-“- |
20 ml, 15-20 % (150-200 mg/ml) |
Human C1-esterase inhibitor |
vials, lyophilisate for solution for intravenous administration |
1 МО |
Anakinra |
pre-filled syringes |
100 mg/ 0,67 ml |
Itraconazole |
pills |
100 mg |
Itraconazole |
vials |
150 ml № 1 with dispenser, oral solution, 10 mg / ml |
Voriconazole |
pills |
50 mg |
Voriconazole |
-“- |
200 mg |
Voriconazole |
vials, powder for solution for infusion |
200 mg |
Amphotericin B |
vials, lyophilisate for solution for infusion |
50 mg |
Posaconazole |
oral suspension |
40 mg / ml, 105 ml in a vial |
Sodium colistimethate |
vials, powder for solution for infusion |
1 mln МО |
Teicoplanin |
vials, lyophilisate for solution for infusion |
200 mg |
Teicoplanin |
-“- |
400 mg |
Filgrastim |
solution for injection |
300 мкг / ml (30 million IU) 1 ml in a vial |
Kanakinumab |
ampoules, vials, syringes |
150 mg |
Sirolimus |
pills |
1 mg |
Medicines and small laboratory equipment to ensure the treatment of infertility in women through assisted reproductive technologies
Chorionic gonadotropin or |
ampoules, powder for solution for injection, |
5 000 МО/ 6 500 МО |
Follitropin alfa |
ampoules, vials, powder for solution for injection, |
75 МО |
Follitropin alfa |
ampoules, vials, syringes, cartridges, powder |
300 МО (22 мкг)/ 0,5 мл |
Follitropin beta |
ampoules, vials, syringes, cartridges, solution |
833 МО/мл |
Propofol |
ampoules, vials, syringes |
10 мг/мл, 20 мл |
Triptorelin |
ampoules, vials, syringes, solution for injection, |
3,75 мг |
Menotropin |
ampoules, vials, syringes, powder for solution, |
75 МО |
Ganirelix or Cetrorelix |
ampoules, vials, syringes |
0,25 мг/ 0,5 мл |
Medicines for citizens suffering from pulmonary hypertension
Iloprost |
solution for inhalation, ampoules |
10 μg / ml, 2 ml |
Sildenafil |
film-coated tablets |
20 mg |
Bosentan |
pills |
62,5 mg |
Bosentan |
-“- |
125 mg |
Ambrizentan |
-“- |
5 mg |
Ambrizentan |
-“- |
10 mg |
Medicines for children with cerebral palsy
Botulinum toxin type A |
ampoules, vials, syringes |
300 UNITS or |
Medicines for citizens with cystic fibrosis
Dornaza Alpha |
solution for inhalation |
2.5 mg / 2.5 ml |
Pancreatin |
microgranules |
in 1 capsule |
Pancreatin |
minimicrospheres |
in 1 capsule |
Pancreatin |
- “- |
in 1 capsule |
Sodium colistimethate |
powder for solution for injection, infusion |
2 million IU |
Medicines for antiretroviral therapy for adults, adolescents and children
Abacavir |
solution for oral administration |
20 мг/мл, 1мл |
Abacavir / lamivudine |
tablets |
600 мг/300 мг |
Abacavir / lamivudine |
soluble tablets |
60 мг/30 мг |
Abacavir / lamivudine |
tablets |
600 мг/ 300 мг |
Atazanavir / ritonavir |
tablets, capsules |
300 мг/100 мг |
Darunavir |
tablets |
600 мг |
Darunavir |
tablets |
400 мг |
Dolutegravir |
- “- |
50 мг |
Dolutegravir |
- “- |
10 мг |
Zidovudine |
solution for oral administration |
10 мг/мл, 1мл |
Zidovudine / lamivudine |
tablets |
300 мг/150 мг |
Zidovudine / lamivudine |
soluble tablets |
60 мг/30 мг |
Efavirenz |
tablets, capsules |
200 мг |
Efavirenz |
tablets |
600 мг |
Lamivudine |
- “- |
150 мг |
Lamivudine |
solution for oral administration |
10 мг/мл, 1мл |
Lopinavir / ritonavir |
tablets |
200 мг/50 мг |
Lopinavir / ritonavir |
- “- |
100 мг/25 мг |
Lopinavir / ritonavir |
solution for oral administration |
80 мг/20 мг, 1мл |
Nevirapine |
suspension for oral administration |
10 мг/мл, 1 мл |
Raltegravir |
tablets |
400 мг |
Raltegravir |
chewable tablets |
100 мг |
Ritonavir |
tablets, capsules |
100 мг |
Tenofovir / emtricitabine |
tablets |
300 мг/ 200 мг |
Tenofovir / emtricitabine |
- “- |
300 мг/ 200 мг |
Tenofovir / lamivudine |
- “- |
300 мг/ 300 мг |
Tenofovir / lamivudine |
tablets |
300 мг/ 300 мг |
Tenofovir alafenamide |
- “- |
25 мг/ 200 мг |
Medicines for treatment of tuberculosis
Isoniazid |
tablets, capsules, pills |
300 mg |
Isoniazid |
- “- |
100 mg |
Isoniazid |
bottles, vials (syrup) |
100 mg/5 ml |
Isoniazid |
ampoules, vials, syringes |
100 mg/ml |
Rifampicin |
tablets, capsules, pills |
150 mg |
Rifampicin |
ampoules, vials, syringes |
600 mg |
Rifapentin |
tablets, capsules, pills |
150 mg |
Rifabutin |
- “- |
150 mg |
Pyrazinamide |
- “- |
500 mg |
Pyrazinamide |
dispersed tablets |
150 mg |
Ethambutol |
tablets, capsules, pills |
400 mg |
Ethambutol |
dispersed tablets |
100 mg |
Ethambutol |
ampoules, vials, syringes |
100 mg/ml |
Rifampicin / isoniazid |
tablets, capsules, pills |
150 mg/75 mg |
Rifampicin / isoniazid |
dispersed tablets |
75 mg/50 mg |
Rifapentin / isoniazid |
tablets, capsules, pills |
300 mg/300 mg |
Rifampicin / isoniazid |
dispersed tablets |
75 mg / 50 mg |
Rifampicin / isoniazid |
tablets, capsules, pills |
150 mg / 75 mg |
Amikacin |
ampoules, vials, syringes |
1,000 mg |
Prothionamide |
tablets, capsules, pills |
250 mg |
Ethionamide |
dispersed tablets |
125 mg |
Levofloxacin |
tablets, capsules, pills |
250 mg |
Levofloxacin |
- “- |
500 mg |
Levofloxacin |
dispersed tablets |
100 mg |
Levofloxacin |
ampoules, vials, syringes |
5 mg / ml |
Moxifloxacin |
tablets, capsules, pills |
400 mg |
Moxifloxacin |
dispersed tablets |
100 mg |
Moxifloxacin |
ampoules, vials, syringes |
400 mg |
Sodium aminosalicylate |
powder, enteric granules |
equivalent to 1 g |
Cycloserine |
tablets, capsules, pills |
250 mg |
Cycloserine |
- “- |
125 mg |
Terizidone |
- “- |
250 mg |
Clofazimine |
- “- |
100 mg |
Clofazimine |
- “- |
50 mg |
Linezolid |
- “- |
600 mg |
Linezolid |
ampoules, vials, syringes |
2 mg / ml |
Amoxicillin with clavulanic acid |
tablets, capsules, pills |
500 mg / 125 mg |
Amoxicillin with clavulanic acid |
bottles, vials (powder for oral suspension) |
125 mg / 31.25 mg |
Amoxicillin with clavulanic acid |
ampoules, vials, syringes |
1,000 mg / 200 mg |
Imipenem with cilastatin |
- “- |
500 mg / 500 mg |
Meropenem |
- “- |
1,000 mg |
Bedaquiline |
tablets, capsules, pills |
100 mg |
Bedaquiline |
- “- |
20 mg |
Delamanid |
- “- |
50 mg |
Pretomanid |
- “- |
200 mg |
Medicines for patients with infectious diseases accompanied by a high mortality rate
Anti-botulinum serum (antitoxin) |
vials, ampoules |
20 ml or 50 ml, contains: |
Diphtheria serum |
vials, ampoules |
10,000 IU, 20,000 IU |
Tetanus antitoxin (human) |
- “- |
250 IU, 500 IU, 1,000 IU, 1,500 IU |
Tetanus immunoglobulin (equine) |
- “- |
1,000 IU, 1,500 IU |
Antirabies immunoglobulin (human) |
- “- |
150 IU, 200 IU, 300 IU |
Artesunat |
- “- |
60 mg of anhydrous artesunate |
Artemether / lumefantrine |
tablets, capsules |
API ratio 1/6 mg (20/120 mg) |
Medications for substitution maintenance therapy
Methadone |
tablets |
5 mg |
Methadone |
-“- |
10 mg |
Methadone |
tablets |
25 mg |
Methadone |
-“- |
40 mg |
Methadone |
oral solution |
1 mg/ml |
Methadone |
-“- |
5 mg/ml |
Buprenorphine |
sublingual tablets |
2 mg |
Buprenorphine |
-“- |
4 mg |
Buprenorphine |
-“- |
8 mg |
Medicines for citizens suffering from orphan metabolic diseases
Alglucosidase alpha |
powder for concentrate for solution |
50 mg |
Agalsidase alpha |
concentrate for solution for infusion |
1 mg / ml 3.5 ml |
Agalsidase beta |
powder for concentrate for solution |
35 mg |
Agalsidase beta |
- “- |
5 mg |
Nitisinone |
hard capsules |
2 mg |
Nitisinone |
- “- |
5 mg |
Nitisinone |
- “- |
10 mg |
Sapropterin dihydrochloride |
tablets |
100 mg |
Laronidase |
concentrate for solution for infusion, |
100 IU / ml |
Idursulfase |
concentrate for solution for infusion, |
2 mg / ml |
Galsulfase |
concentrate for solution for infusion, |
1 mg / ml |
Elosulfase alpha |
concentrate for solution for infusion, |
1 mg / ml |
Velaglucerase alpha |
ampoules, vials, syringes |
400 OD |
Taliglucerase alpha |
- “- |
200 OD |
Imiglucerase |
- “- |
400 OD |
Imiglucerase or taliglucerase alpha, or velaglucerase alpha |
- “- |
200 UNITS or 400 UNITS |
Purchase of kits for 4 million PCR tests (medical devices and accessories for testing for acute respiratory disease COVID-19 caused by coronavirus SARS-CoV-2, polymerase chain reaction)
Kits for laboratory studies by polymerase chain reaction |
set |
Medicines and immunobiological drugs to prevent the introduction and spread in Ukraine of acute respiratory disease COVID-19 caused by coronavirus SARS-CoV-2
Tocilizumab |
ampoules, vials, syringes |
200 mg / 10 ml |
Remdesivir |
- “- |
100 mg |
Human immunoglobulin is normal for intravenous administration |
ampoules, vials, syringes |
5 g (10 %) per 100 |